Eva Lion

3.8k citations
64 papers · 2.7k · 1 hit paper · h-index 29

Impact in

  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune cells in cancer
  • Oncology top 2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immunotherapy and Immune Responses 41
    • Immune Cell Function and Interaction 30
    • T-cell and B-cell Immunology 12
    • CAR-T cell therapy research 28
    • Cancer Immunotherapy and Biomarkers 8

Eva Lion

62 papers receiving 2.7k citations

Eva Lion's Hit Papers

Clinical use of dendritic cells for cancer therapy 2014 · 569 citations
5690+4+8Years since publication100200300400500

Peers

Eva Lion
Comparison fields: 5 of 100
  • Immunology 1.9k
  • Oncology 1.3k
  • Hematology 247
  • Molecular Biology 706
  • Biotechnology 83
Replace Martin Felices with:
Martin Felices United States
Liquan Gao United Kingdom
Willemijn Hobo Netherlands
Sébastien Anguille Belgium
Robbert van der Voort Netherlands
Andrei I. Chapoval United States
Robin Parihar United States
Anja Feldmann Germany
Maite Álvarez United States
Fabrice Lemaı̂tre France
Eva Lion relative to Martin Felices United States Martin Felices's profile →
Citations per field
00.5×1.6×
Martin Felices · 1×
Citations per year

Countries citing papers authored by Eva Lion

Since Specialization
Citations

This map shows the geographic impact of Eva Lion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lion more than expected).

Fields of papers citing papers by Eva Lion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Lion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lion. The network helps show where Eva Lion may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Lion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Lion Line = papers co-authored together Eva Lion links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical use of dendritic cells for cancer therapy
Hit paper breakdown →
2014569
2 2014147
3 2012129
4 2020128
5 2015127
6 2016101
7 201996
8 201191
9 201878
10 201270
11 201963
12 202060
13 201756
14 200955
15 201553
16 201953
17 201550
18 201249
19 201748
20 201247

About Eva Lion

Eva Lion is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biotechnology, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (30 papers), CAR-T cell therapy research (28 papers), T-cell and B-cell Immunology (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), RNA Interference and Gene Delivery (7 papers), CRISPR and Genetic Engineering (4 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Immunology (1.9k citations), Oncology (1.3k citations), Hematology (247 citations), Molecular Biology (706 citations) and Biotechnology (83 citations). Eva Lion has collaborated with scholars based in Belgium, Uganda and Netherlands. Frequent co-authors include Evelien Smits, Viggo Van Tendeloo, Zwi Berneman, Sébastien Anguille, Yannick Willemen, Diana Campillo-Davó, Heleen H. Van Acker, Donovan Flumens, Jorrit De Waele and Herman Goossens. Their work appears in journals such as Oncotarget, Frontiers in Immunology, PLoS ONE, Cancers and Cytotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact